首页> 外文期刊>The Endocrinologist >A Case of Pituitary Apoplexy Induced by a Bromocriptine Test With a TSH- and GH-Producing Pituitary Adenoma
【24h】

A Case of Pituitary Apoplexy Induced by a Bromocriptine Test With a TSH- and GH-Producing Pituitary Adenoma

机译:溴隐亭试验导致TSH和GH产生的垂体腺瘤诱发垂体中风的一例

获取原文
获取原文并翻译 | 示例
           

摘要

We report a 54-year-old Japanese woman with enlargement of her hands and feet, and tachycardia over the previous 3 years. She had a TSH- and GH-producing pituitary adenoma 3.5 X 3.0 X 2.0 cm. A bromocriptine test was performed. Bromocriptine was slightly effective for GH inhibition, but, she complained of headaches, nausea, and impaired vision 24 hours after bromocriptine administration. MRI examination showed heterogeneous mixed intensity lesions in the pituitary adenoma, compatible with pituitary apoplexy. The tumor was removed by the transsphenoidal approach 24 hours later, and histologic examination confirmed the diagnosis of pituitary apoplexy. Although pituitary apoplexy associated with bromocriptine is very rare, this case suggests a casual relationship is possible in some instances.
机译:我们报道了一名54岁的日本女性,过去3年中手脚增大,心动过速。她患有TSH和GH产生的垂体腺瘤3.5 X 3.0 X 2.0 cm。进行了溴隐亭试验。溴隐亭对GH的抑制作用较轻,但她抱怨溴隐亭投药24小时后出现头痛,恶心和视力受损。 MRI检查显示垂体腺瘤的混合强度混合灶不均匀,与垂体中风兼容。 24小时后经蝶窦入路切除肿瘤,组织学检查证实为垂体中风。尽管与溴隐亭有关的垂体中风非常罕见,但这种情况表明在某些情况下可能存在偶然的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号